p14^ARF, p15^INK4b and p16^INK4a Methylation Status in Chronic Myelogenous Leukemia

References

• Hannon, G.J. and Beach, D. (1994) "p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest", Nature, 371, 257 — 261.
   Google Scholar
• Sherr, C.J. and Roberts, J.M. (1995) "Inhibitors of mammalian GI cyclin-dependent lcinases", Genes Dev., 9, 1149–1163.
   PubMed Web of Science ®Google Scholar
• Kim, S.J. and Letterio, J. (2003) "Transforming growth factor-beta signaling in normal and malignant hematopoiesis", Leukemia, 17, 1731 — 1737.
   Web of Science ®Google Scholar
• Lowe, SM. and Sherr, C.J. (2003) "Tumor suppression by Ink4a-Arf: progress and puzzles", Curr. Opin. Genet. Dev., 13, 77–83.
   Web of Science ®Google Scholar
• Sugimoto, M., Kuo, ML., Roussel, M.F. and Sherr, C.J. (2003) "Nucleolar Arf tumor suppressor inhibits ribosomal RNA proces-sing", MoL Cell, 11, 415–424.
   Google Scholar
• Krug, U., Ganser, A. and Koeffler, H.P. (2002) "Tumor suppressor genes in normal and malignant hematopoiesis", Oncogene, 21, 3475–3495.
   Google Scholar
• Esteller, M., Corn, P.G., Baylin, S.B. and Herman, J.G. (2001) "A gene hypermethylation profile of human cancer", Cancer Res., 61, 3225–3229.
   PubMed Web of Science ®Google Scholar
• Drexler, H.G. (1998) "Review of alterations of the cyclin-dependent lcinase inhibitor INK4 family genes pI5, pI6, p18 and p19 in human leukemia-lymphoma cells", Leukemia, 12, 845–859.
   PubMed Web of Science ®Google Scholar
• Drayton, S., Rowe, J., Jones, R., Vatcheva, R., Cuthbert-Heavens, D., Marshall, J., et al. (2003) "Tumor suppressor p 16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes", Cancer Cell, 4, 301–310.
   PubMed Web of Science ®Google Scholar
• Esteller, M. (2002) "CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future", Oncogene, 21, 5427–5440.
   PubMed Web of Science ®Google Scholar
• Jones, P.A. and Baylin, S.B. (2002) "The fundamental role of epigenetic events in cancer", Nat. Rev. Genet., 3, 415–428.
   Web of Science ®Google Scholar
• Jaenisch, R. and Bird, A. (2003) "Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals", Nat. Genet., 33(Suppl), 245–254.
   Google Scholar
• Uchida, T., Kinoshita, T., Hotta, T. and Murate, T. (1998) "High-risk myelodysplastic syndromes and hypermethylation of the pl5Ink4B gene", Leuk. Lymphoma, 32, 9 — 18.
   PubMed Web of Science ®Google Scholar
• Quesnel, B. and Fenaux, P. (1999) "P15INK4b gene methylation and myelodysplastic syndromes", Leuk. Lymphoma, 35, 437–443.
   PubMed Web of Science ®Google Scholar
• Lubbert, M. (2003) "Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?", Leukemia, 17, 1762–1764.
   Google Scholar
• Daskalakis, M., Nguyen, T.T., Nguyen, C., Guldberg, P., Kohler, G., Wijermans, P., et al. (2002) "Demethylation of a hypermethy-lated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment", Blood, 100, 2957–2964.
   PubMed Web of Science ®Google Scholar
• Issa, J.P. (2003) "Decitabine", Curr. Opin. OncoL, 15, 446–451.
   PubMedGoogle Scholar
• Issa, J.P., Garcia-Manero, G., Giles, F.J., Mannari, R., Thomas, D., Faderl, S., et al. (2004) "Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycy-tidine (decitabine) in hematopoietic malignancies", Blood, 103, 1635 — 1640.
   PubMed Web of Science ®Google Scholar
• Herman, J.G., Civin, CI., Issa, J.P., Collector, MI., Sharlcis, S.J. and Baylin, S.B. (1997) "Distinct patterns of inactivation of p I5INK4B and p 16INK4A characterize the major types of hematological malignancies", Cancer Res., 57, 837–841.
   PubMed Web of Science ®Google Scholar
• Sawyers, C.L. (1999) "Chronic myeloid leukemia", N. Engl. J. Med., 340, 1330–1340.
   Google Scholar
• Nagy, E., Beck, Z., Kiss, A., Csoma, E., Telek, B., Konya, J., et al. (2003) "Frequent methylation of p 16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase", Eur. J. Cancer, 39, 2298–2305.
   Web of Science ®Google Scholar
• Taniguchi, T., Chikatsu, N., Takahashi, S., Fujita, A., Uchimaru, K., Asano, S., etal. (1999) "Expression of pl6INK4A and p I4ARF in hematological malignancies", Leukemia, 13, 1760–1769.
   Web of Science ®Google Scholar
• Kusy, S., Cividin, M., Sorel, N., Brizard, F., Guilhot, F., Brizard, A., et al. (2003) "p14ARF, p I5INK4b, and p I6INK4a methylation status in chronic myelogenous leukemia", Blood, 101, 374–375.
   PubMed Web of Science ®Google Scholar
• Nguyen, T.T., Mohrbacher, A.F., Tsai, Y.C., Groffen, J., Heister-kamp, N., Nichols, P.W., et al. (2000) "Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications", Blood, 95, 2990–2992.
   PubMed Web of Science ®Google Scholar
• Hernandez-Boluda, J.C., Cervantes, F., Colomer, D., Vela, M.C., Costa, D., Paz, M.F., et al. (2003) "Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis: a sequential study in 42 patients", Exp. HematoL, 31, 204–210.
   Web of Science ®Google Scholar
• Ogawa, S., Hangaishi, A., Miyawalci, S., Hirosawa, S., Miura, Y., Takeyama, K., et al. (1995) "Loss of the cyclin-dependent lcinase 4-inhibitor (p16; MTSI) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies", Blood, 86, 1548–1556.
   PubMed Web of Science ®Google Scholar
• Heyman, M. and Einhorn, S. (1996) "Inactivation of the p I5INK4B and p 16INK4 genes in hematologic malignancies", Leuk. Lympho-ma, 23, 235–245.
   PubMed Web of Science ®Google Scholar
• Iolascon, A., Della Ragione, F., Giordani, L., Serra, A., Saglio, G. and Faienza, M.F. (1998) "Expression of cell cycle regulatory genes in chronic myelogenous leukemia", Haematologica, 83, 771–777.
   Google Scholar
• Sill, H., Goldman, J.M. and Cross, N.C. (1995) "Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia", Blood, 85, 2013–2016.
   Google Scholar
• Serra, A., Gottardi, E., Della Ragione, F., Saglio, G. and Iolascon, A. (1995) "Involvement of the cyclin-dependent lcinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia", Br. J. Haematol., 91, 625–629.
   Web of Science ®Google Scholar
• Diccianni, MB., Batova, A., Yu, J., Vu, T., Pullen, J., Amylon, M., et al. (1997) "Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions", Leuk. Res., 21, 549–558.
   Google Scholar
• Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. and Baylin, S.B. (1996) "Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands", Proc. Natl. Acad. Sci. USA, 93, 9821 —9826.
   PubMed Web of Science ®Google Scholar
• Esteller, M., Tortola, S., Toyota, M., Capella, G., Peinado, M.A., Baylin, S.B., et al. (2000) "Hypermethylation-associated inactiva-tion of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status", Cancer Res., 60, 129–133.
   PubMed Web of Science ®Google Scholar
• Baylin, S.B. and Herman, J.G. (2000) "DNA hypermethylation in tumorigenesis: epigenetics joins genetics", Trends Genet., 16, 168 — 174.
   Google Scholar